Expression of basic fibroblast growth factor is associated with poor outcome in non-Hodgkin's lymphoma

British Journal of Cancer

Volumn 86, Issue 11, 2002, Pages 1770-1775

  Pazgal, I ^a   Zimra, Y ^a   Tzabar, C ^a   Okon, E ^a   Rabizadeh, E ^a   Shaklai, M ^a   Bairey, O ^a  

^a RABIN MEDICAL CENTER   (Israel)

Author keywords

Basic fibroblast growth factor; Basic fibroblast growth factor receptor; Immunohistochemistny; Microvessel count; Non Hodgkin's lymphoma

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; BLOOD CLOTTING FACTOR 7; FIBROBLAST GROWTH FACTOR RECEPTOR 1;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER REGRESSION; CANCER SURVIVAL; CAPILLARY DENSITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MICROVASCULATURE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; TUMOR VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; FACTOR VIII; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0037024415     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600330     Document Type: Article

References (23)

1. The FGF family of growth factors and oncogenes
2. Biological roles of fibroblast growth factor-2
3. Role of FGFs and FGF receptors in human carcinogenesis
4. Basic fibroblast growth factor receptors and their prognostic value in human breast cancer
5. Expression of basic fibroblast growth factor and its receptor by head and neck squamous carcinoma tumor and vascular endothelial cells
6. What is the evidence that tumors are angiogenesis dependent?
7. Alteration in expression of basic fibroblast growth factor (FGF)2 and its receptor FGFR-1 in human prostate cancer
8. Basic fibroblast growth factor is expressed by CD19/CD11c-positive cells in hairy cell leukemia
9. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airline House, Virginia, November 1997
10. Angiogenesis: A dynamic balance of stimulators and inhibitors
11. Angiogenesis and angiogenic mediators in haematological malignancies
12. Elevated intracellular level of basic fibroblast growth factor correlates with stage of chronic lymphocytic leukemia and is associated with resistance to fludarabine
13. Expression of basic fibroblast growth factor and its receptor in human pancreatic carcinomas
14. Clinical implications of circulating angiogenic factors in cancer patients
15. Angiogenesis spectrum in the stroma of B-cell non-Hodgkin's lymphomas. An immunohistochemical and ultrastructural study
16. A high pretreatment serum basic fibroblast growth factor concentration is an independent predictor of poor prognosis in non-Hodgkin's lymphoma
17. Serum levels of the angiogenic cytokines basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in multiple myeloma
18. A predictive model for aggressive non-Hodgkin's lymphoma
19. Clinical significance of the determination of angiogenic factors
20. Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma
21. Prognostic value of basic fibroblast growth factor and its receptor (FGFR-1) in patients with non-small lung carcinomas
22. Expression of basic fibroblast growth factor (FGF-2)-associated with tumor proliferation in human pancreatic carcinoma
23. Fibroblast growth factor 2 in breast cancer: Occurrence and prognostic significance